Singer I I, Scott S, Chin J, Bayne E K, Limjuco G, Weidner J, Miller D K, Chapman K, Kostura M J
Department of Immunology and Inflammation, Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA.
J Exp Med. 1995 Nov 1;182(5):1447-59. doi: 10.1084/jem.182.5.1447.
Interleukin-1 beta (IL-1 beta)-converting enzyme (ICE) is a novel cysteine protease that cleaves the 31-kD inactive cytoplasmic IL-1 beta precursor into active extracellular 17-kD IL-1 beta. The ICE gene product is a 45-kD proenzyme that requires proteolytic processing to activate ICE. Active ICE is a heterodimer consisting of equal amounts of p20 and p10 subunits. Generation of active ICE is affected by the removal of an 11-kD NH2-terminal precursor domain (p11) and an internal 19-amino acid sequence that separates the 20- and 10-kD subunits. Immuno-electron microscopy was performed on human monocytes with immunoglobulins recognizing the active (p20) or precursor (p11) domains of ICE. Elutriated monocytes were stimulated with 50 pM lipopolysaccharide followed by heat-killed Staphylococcus aureus under conditions that induce maximal rates of IL-1 beta secretion. Ultrathin cryosections were cut from fixed frozen pellets of these monocytes and were immunogold labeled with either antibody. Active and precursor domain ICE epitopes were localized in the cytoplasmic ground substance, but they were not detected within the endoplasmic reticulum, the Golgi apparatus, and secretory granules of activated or inactive monocytes. Importantly, numerous ICE p20 epitopes were also observed on the extracellular surfaces of the cell membrane, and were concentrated on the microvilli. Very similar patterns of ICE localization were obtained with unstimulated blood monocytes. In contrast, ICE p11 epitopes were not detected on the surfaces of these monocytes. Likewise, labeling of fixed ultrathin cryosections of monocytes with a biotinylated irreversible ICE inhibitor [Ac-Tyr-Val-Lys(biotin)-Asp-(acyloxy)-methyl-ketone] showed that the compound localized on the outer cell surface as well, and to a lesser extent, within the cytoplasmic ground substance. Furthermore, antipeptide antibodies specific for either the mature or precursor domains of IL-1 beta were both localized upon the cell membrane after stimulation of IL-1 beta secretion. Lipopolysaccaride-primed monocytes that synthesized, but did not secrete IL-1 beta, exhibited only cytoplasmic staining. The data suggests that mature IL-1 beta is generated via cleavage of the 31-kD inactive cytoplasmic IL-1 beta precursor by ICE after association with the plasma membrane during secretion.
白细胞介素-1β(IL-1β)转化酶(ICE)是一种新型半胱氨酸蛋白酶,它可将31kD无活性的细胞质IL-1β前体切割成活性细胞外17kD的IL-1β。ICE基因产物是一种45kD的酶原,需要进行蛋白水解加工才能激活ICE。活性ICE是一种异二聚体,由等量的p20和p10亚基组成。活性ICE的产生受11kD NH2末端前体结构域(p11)和分隔20kD和10kD亚基的内部19个氨基酸序列去除的影响。用识别ICE活性(p20)或前体(p11)结构域的免疫球蛋白对人单核细胞进行免疫电子显微镜检查。用50pM脂多糖刺激淘洗后的单核细胞,然后在诱导IL-1β分泌最大速率的条件下用热灭活的金黄色葡萄球菌刺激。从这些单核细胞的固定冷冻沉淀中切取超薄冷冻切片,并用两种抗体进行免疫金标记。活性和前体结构域ICE表位定位于细胞质基质中,但在活化或未活化单核细胞的内质网、高尔基体和分泌颗粒中未检测到。重要的是,在细胞膜的细胞外表面也观察到大量ICE p20表位,并且集中在微绒毛上。未刺激的血液单核细胞也获得了非常相似的ICE定位模式。相反,在这些单核细胞的表面未检测到ICE p11表位。同样,用生物素化的不可逆ICE抑制剂[Ac-Tyr-Val-Lys(生物素)-Asp-(酰氧基)-甲基酮]对单核细胞的固定超薄冷冻切片进行标记显示,该化合物也定位于细胞外表面,且在较小程度上定位于细胞质基质中。此外,在刺激IL-1β分泌后,对IL-1β成熟或前体结构域特异的抗肽抗体均定位于细胞膜上。合成但未分泌IL-1β的脂多糖致敏单核细胞仅表现出细胞质染色。数据表明,成熟的IL-1β是在分泌过程中与质膜结合后,由ICE对31kD无活性的细胞质IL-1β前体进行切割而产生的。